End-of-day quote
Other stock markets
|
||
- USD | - |
14/05 | Transcript : CV Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | CV Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 1.62Cr 134.85Cr | Sales 2023 | 1.6Cr 133.17Cr | Capitalization | 54.65L 45Cr |
---|---|---|---|---|---|
Net income 2022 | -90L -75Cr | Net income 2023 | 30L 25Cr | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 9L 7.63Cr | Net cash position 2023 | 9L 7.28Cr | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CannaVEST Corp
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16/14/16 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 26/18/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16/14/16 |
Jamie Corroon
BRD | Director/Board Member | 54 | 21/22/21 |
William McCorkle
BRD | Director/Board Member | 56 | 21/22/21 |
1st Jan change | Capi. | |
---|---|---|
+37.74% | 72TCr | |
+34.49% | 59TCr | |
-2.07% | 37TCr | |
+20.25% | 33TCr | |
+2.99% | 28TCr | |
+17.06% | 24TCr | |
+9.79% | 21TCr | |
-4.25% | 21TCr | |
+2.81% | 17TCr |